<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03338738</url>
  </required_header>
  <id_info>
    <org_study_id>COPROBLSE</org_study_id>
    <nct_id>NCT03338738</nct_id>
  </id_info>
  <brief_title>Impact of Antibiotics on Fecal Abundance du to EBLSE</brief_title>
  <official_title>Impact of Antibiotics on Fecal Abundance du to EBLSE</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Groupe Hospitalier Paris Saint Joseph</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>APHP - HOPITAL AVICENNE</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Groupe Hospitalier Paris Saint Joseph</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Among the enterobacteria , the production of ESBL(extended-spectrum beta-lactamases) is the
      first cause of multi-resistance.

      Also the infections due to these EBSL are increasing ; it is therefore necessary to evaluate
      the impact of different antibiotics on the healthy tract flora modification and on the faecal
      abundance due to ESBL.

      The study has for main objective to estimate in vivo the impact of the various beta one -
      lactamines on the relative faecal abundance enterobacteria producers of EBLS in ICU patients
      presenting a rectal colonization known in enterobacteria ESBL.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 1, 2017</start_date>
  <completion_date type="Anticipated">December 2019</completion_date>
  <primary_completion_date type="Anticipated">June 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>percentage of EBLSE</measure>
    <time_frame>Day 60</time_frame>
    <description>ratio of number of colony of enterobacteria BLSE on number of total bacteria colony</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Enterobacterial Infection</condition>
  <arm_group>
    <arm_group_label>stool culture and swab ESBL positive</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>stool culture ans swab</intervention_name>
    <description>each patient with ESBL positive result will be diagnosed by stool culture and rectal swab</description>
    <arm_group_label>stool culture and swab ESBL positive</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age&gt; 18

          -  ICU admitted patient

          -  rectal colonization of Enterobacteria

          -  accepting participation

          -  with medical insurance

        Exclusion Criteria:

          -  patient without bacterial colonization

          -  under antibiotics more than 24hours

          -  without medical insurance
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>ZAHAR Jean Ralph, Professor</last_name>
    <role>Study Chair</role>
    <affiliation>AVICENNE HOSPITAL</affiliation>
  </overall_official>
  <overall_official>
    <last_name>LE MONNIER Alban, Professor</last_name>
    <role>Study Director</role>
    <affiliation>GHPSJ</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>PILMIS Benoit, MD</last_name>
    <phone>01 44 12 33 33</phone>
    <email>bpilmis@hpsj.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>PHILIPPART Francois, MD</last_name>
    <email>fphilipart@hpsj.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Groupe Hospitalier Paris Saint Joseph</name>
      <address>
        <city>Paris</city>
        <state>Ile-de-France</state>
        <zip>75014</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Helene BEAUSSIER, PharmD, PhD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 19, 2017</study_first_submitted>
  <study_first_submitted_qc>November 8, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">November 9, 2017</study_first_posted>
  <last_update_submitted>November 8, 2017</last_update_submitted>
  <last_update_submitted_qc>November 8, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 9, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Enterobacteriaceae Infections</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anti-Bacterial Agents</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

